Apathy in first episode psychosis patients: one year follow up

Schizophrenia Research
Ann FaerdenIngrid Melle

Abstract

This study describes how the negative subsyndrome of apathy develops over the first year in first episode psychosis (FEP) patients, with an emphasis on the prevalence of enduring apathy and the relationship between apathy, other symptoms and functioning. Eighty four FEP patients were assessed both at baseline and after one year with the abridged clinical version of the Apathy Evaluation Scale (AES-C-Apathy). Other symptoms were assessed with the Positive and Negative syndrome scale (PANSS) and functioning with the split version of the Global Assessment of Functioning Scale (GAF-F). The mean level of AES-C-Apathy decreased from baseline to the one year follow up for the whole group of FEP patients. High levels of apathy at 1year were best predicted by high levels of apathy at baseline, a long DUP and a diagnosis within the Schizophrenia spectrum. The presence of depression and level of medication only had a minor influence. AES-C-Apathy had a stronger association to GAF-F than other PANSS symptom areas. Twenty five (30%) FEP patients had high enduring levels of apathy. This group consisted of significantly more males, had a longer duration of untreated psychosis, a greater likelihood of a Schizophrenia spectrum diagnosis, fewer ...Continue Reading

References

Aug 1, 1991·Psychiatry Research·R S MarinS Firinciogullari
Nov 1, 1989·Psychiatry Research·B KirkpatrickW T Carpenter
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jan 1, 1982·Schizophrenia Bulletin·H E Cannon-SpoorR J Wyatt
Jul 1, 1982·Archives of General Psychiatry·N C Andreasen
May 15, 1995·Biological Psychiatry·A L MillerJ W Maas
Jan 1, 1997·Clinical Psychology Review·K S Earnst, A M Kring
Aug 15, 2000·Trends in Neurosciences·R G Brown, G Pluck
Nov 20, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·G C Pluck, R G Brown
Jan 2, 2004·The American Journal of Psychiatry·Robert M RothRobert Vidaver
Jul 3, 2004·The Journal of Nervous and Mental Disease·Ashok K MallaRaj Haricharan
Aug 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Tor K LarsenThomas H McGlashan
Sep 9, 2004·Acta Psychiatrica Scandinavica·S FriisT H McGlashan
Feb 17, 2006·Schizophrenia Bulletin·Brian KirkpatrickStephen R Marder
Feb 24, 2006·Schizophrenia Bulletin·Stephen M ErhartWilliam T Carpenter
Nov 14, 2006·Schizophrenia Bulletin·Robert W Buchanan
Dec 6, 2006·Comprehensive Psychiatry·Geir PedersenSigmund Karterud
Apr 28, 2007·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Ulrike LuekenJohannes Schröder
Nov 22, 2007·European Psychiatry : the Journal of the Association of European Psychiatrists·Ann FaerdenIngrid Melle
Jan 10, 2009·BMC Psychiatry·Ann FaerdenIngrid Melle
Jan 1, 1997·European Psychiatry : the Journal of the Association of European Psychiatrists·H GerbaldoD Pieschl
Nov 3, 2009·Psychiatric Services : a Journal of the American Psychiatric Association·Ann FaerdenIngrid Melle

❮ Previous
Next ❯

Citations

Aug 21, 2013·L'Encéphale·H YazbekD Capdevielle
Aug 6, 2013·Psychiatry Research·Gagan FervahaGary Remington
Jan 24, 2012·Cognitive Neuropsychiatry·Céline Delerue, Muriel Boucart
Nov 11, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Max LamJimmy Lee
Jan 31, 2012·Schizophrenia Research·Julie EvensenThomas McGlashan
Aug 6, 2010·Schizophrenia Research·Elizabeth A BarrettIngrid Melle
Apr 20, 2010·Schizophrenia Research·Elizabeth A BarrettIngrid Melle
Mar 31, 2015·Schizophrenia Research·Lynn Mørch-JohnsenIngrid Agartz
Oct 30, 2012·Schizophrenia Research·Aina HolménIngrid Melle
May 31, 2014·Schizophrenia Research·Hanan YazbekStéphane Raffard
Dec 17, 2014·Schizophrenia Research·Edith J LiemburgAndré Aleman
Sep 17, 2013·Neuroscience and Biobehavioral Reviews·Gagan FervahaGary Remington
Nov 28, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·George FoussiasGary Remington
Sep 2, 2014·European Psychiatry : the Journal of the Association of European Psychiatrists·C Ergül, A Üçok
Jan 4, 2017·European Psychiatry : the Journal of the Association of European Psychiatrists·W C ChangE Y H Chen
Dec 18, 2014·Journal of Psychopharmacology·George FoussiasGary Remington
Dec 2, 2017·Brain : a Journal of Neurology·Mathias PessiglioneRaphaël Le Bouc
Jan 11, 2017·Scientific Reports·Matthias N Hartmann-RiemerStefan Kaiser
Feb 25, 2011·The Journal of Nervous and Mental Disease·Ragnhild JohansenIngrid Melle
Mar 5, 2020·European Archives of Psychiatry and Clinical Neuroscience·Siv Hege LyngstadAnn Færden
Sep 26, 2019·Frontiers in Neurology·Bénédicte BatrancourtRichard Levy
Jun 24, 2018·European Archives of Psychiatry and Clinical Neuroscience·Wing Chung ChangEric Yu Hai Chen
Jul 5, 2018·Early Intervention in Psychiatry·Michael C HannJong Yoon
Sep 16, 2020·Schizophrenia Research·Achim BurrerMatthias Kirschner
Aug 1, 2021·Journal of Psychiatric Research·AmirHussein AbdolalizadehAmir Sasan Bayani Ershadi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here